The presentation titled 'Optimization Beyond Simulation' covers:
Ahead of the Clinical Trial Supply Forum 2023, we explore the latest trends impacting the end-to-end clinical trial supply chain, to help you build a resilient and effective clinical trial supply chain. In this report, we discuss the challenges affecting the supply chain, causes of supply chain bottlenecks, advantages of advanced IRT systems, and key advice for a successful supply chain.
Download the full report here! >>>
Clinical trial supply chains are constantly evolving, with new technologies and regulations impacting the way that clinical trials are conducted. Ahead of the Clinical Trial Supply Forum 2023, we explore the key trends that are expected to shape the way that clinical trials are conducted globally, to help you build a resilient and effective clinical trial supply chain.
Download the full article here! >>>
With 253,834 studies located in 200 countries, ensuring smooth and cost-effective global clinical trial supply has become a standard for the pharmaceutical industry. Experts from all regions have answered our survey on the main pain points they face, how they can improve their supply chain and what drives its success. Anat Batsri, Global Clinical Supply Chain Study Lead at OPKO Biologics, had a look at the results and gave us her feedback on what the results showed.
In light of the current global Covid-19 crisis there has never been a more critical time to speed up your clinical development and time to market. We at Pharma IQ know that Clinical Supplies play a crucial role in this process so we have created an infographic which explores how innovative data strategies can streamline and accelerate the clinical trial process.
Ahead of the Clinical Trial Supply Forum, experts from all regions and areas within clinical trial supply participated in our survey, to give us insight on the main logistical challenges that exist in global clinical trials. This survey looks at the main challenges and drivers which companies are facing and looks ahead to what this means for the future. It also looks at how things have changed over the last year.
Interested in finding out more about this event? Download the full agenda here.
Clinical trials are on the rise and new designs such as adaptive clinical trials are emerging, requiring flexibility and transparency and forcing pharma companies to re-assess their approach to their supply chain to adapt to these changes. Ahead of the Clinical Trial Supply Forum, we sat down with one of the speakers, Antony Pham, Co-founder of consulting and tech-based SPLY ApS to discuss the opportunities and challenges associated with the implementation of new technologies in the supply chain and how they can increase the companies' efficiency while reducing costs.
CTS delegates enjoyed presentations on topics focused on one single message: Ensuring a lean and efficient clinical trial supply environment – no matter the product, market or phase.
Pharma IQ are providing an outline of the key discussions which took place, the attendees of the conference and insights into where the industry is heading.